As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Abbott Laboratories: Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Readystate Asset Management LP, Point72 DIFC Ltd, Point72 Asset Management L.P., Parallax Volatility Advisers L.P., Centiva Capital LP, Paloma Partners Management Co, Garda Capital Partners LP, Verition Fund Management LLC, Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, BNP Paribas Financial Markets, Citigroup Inc., LMR Partners LLP, Claro Advisors LLC, Gladius Capital Management LP, Wolverine Asset Management LLC, SpiderRock Advisors LLC, IMC Chicago LLC, Wealth Enhancement Advisory Services LLC, Claro Advisors LLC, Concourse Financial Group Securities Inc., Oak Hill Wealth Advisors LLC, SG Americas Securities LLC, and Point72 DIFC Ltd. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.